CORRELATION BETWEEN ISCHEMIC HEART DISEASE AND CHEMOTHERAPY

Ischemic stroke is a condition diagnosed when a blood clot or malignant particle reduces or stops the blood flow to a part of the body. Chemotherapy is a treatment used to cure cancer by killing fast-growing cells redundant to its malignancy. Numerous cancer treatments have shown a statistical relationship with ischemic diseases. Through previous studies and statistics, this research paper will focus on the positive correlation between ischemic heart disease and chemotherapy. This is mainly due to the cause of venous thrombosis (VTE), a side effect generated by drugs used in neoadjuvant chemotherapy and chemotherapy. Substances such as colony-stimulating factors (CSF) and erythropoiesis-stimulating agents (ESA) are examples of substances that generate venous thrombosis. Venous thrombosis is a condition in which a patient's blood flow is impeded through blood clots in the blood vessel and leads to a thrombotic stroke, the most common form of an ischemic stroke. This subject shows significance in the field of medical science and medicine as it shows what factors of drugs used in chemotherapy influence the human blood vessels. Limitations exist in this paper as the lack of resources resulted in the paper being based on pure literature reviews from previous academic papers. Furthermore, specific sources that have been used in the paper were published a decade ago. This research aims to understand the extent of chemotherapy's influence on ischemic strokes and the factors of chemotherapy that cause ischemic strokes. This research paper was written using evidence derived from the experiments and conclusions of previous academic papers. It emphasizes the danger and addresses certain risks of chemotherapy, aiming to be a catalyst for the development of drugs that may combat ischemic strokes in the future.